Larimar Therapeutics, Inc. Earnings Per Share Diluted

Quick Answer

Larimar Therapeutics, Inc. reported Earnings Per Share Diluted of $1.32 (loss) per share for the year ending 2024.

  • Larimar Therapeutics, Inc. showed a decrease of -57.1% in Earnings Per Share Diluted from 2023 to 2024.
  • This data is from Larimar Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 24, 2025.
  • XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2020 to 2024), Larimar Therapeutics, Inc.'s Earnings Per Share Diluted has grown by 63.0%.
  • Historical annual values: Fiscal year 2024: $1.32 (loss) per share | Fiscal year 2023: $0.84 (loss) per share | Fiscal year 2022: $1.37 (loss) per share | Fiscal year 2021: $2.95 (loss) per share | Fiscal year 2020: $3.57 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: